MRK vs UNH: Merck & Co., Inc. vs UnitedHealth Group Incorporated
Side-by-side snapshot of two Healthcare companies — key metrics from our latest data. Reference only, not investment advice.
| Metric | MRK | UNH |
|---|---|---|
| Company | Merck & Co., Inc. | UnitedHealth Group Incorporated |
| Price | $150.33 | $397.14 |
| Market Cap | $370.89B | $356.47B |
| P/E Ratio | 120.26 | 25.51 |
| EPS | $1.25 | $15.57 |
| Dividend Yield | 2.23% | 2.34% |
| 52-Week High | $156.92 | $461.62 |
| 52-Week Low | $77.58 | $255.97 |
| Beta | 0.23 | 0.62 |
| Return on Equity (ROE) | 6.96% | 14.15% |
| Debt-to-Equity | 128.41% | 69.21% |
| Industry | Drug Manufacturers - General | Healthcare Plans |
| Exchange | NYQ | NYQ |
| Employees | 73,000 | 390,000 |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Philip Fisher's growth-investing classic on evaluating management and moats.
Check Price →Keep budgets, portfolios and goals in one place with a dedicated finance planner.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Merck & Co., Inc. and UnitedHealth Group Incorporated both operate in the Healthcare sector. MRK has a market cap of $370.89B versus UNH's $356.47B. On valuation, MRK carries a trailing P/E of 120.26 against 25.51 for UNH. In terms of earnings, MRK posts EPS of $1.25 versus UNH's $15.57. For price range, MRK has traded between $77.58 and $156.92 over the past 52 weeks, and UNH between $255.97 and $461.62. On income, MRK yields 2.23% versus UNH's 2.34%. On volatility, UNH carries the higher beta (MRK 0.23 vs UNH 0.62), meaning it has historically moved more sharply than the market. How these figures compare depends on each company's growth profile, margins and competitive position — this snapshot is a starting point for research, not a recommendation.
Comparing two companies becomes much more powerful once you can read their financials directly — financial statement analysis guides are a practical next step. Many investors track comparisons like this in a dedicated stock research journal.
Figures are from our latest data snapshot and may not reflect current market prices. See the full profiles: Merck & Co., Inc. and UnitedHealth Group Incorporated. This is not financial advice.
Recommended Reading
Jack Bogle's case for low-cost index funds, in under 300 pages.
Check Price →A dedicated finance calculator for TVM, NPV and rate-of-return work.
Check Price →JL Collins' plain-English guide to index investing and financial independence.
Check Price →